We estimate that the CEO of Ingevity Corp ($NGVT), David H. Li, received a compensation of $12,839,719 in 2025.
These estimates are based on a new DEF14A filing, filed with the SEC on March 17, 2026. Note that parsing errors may occur.
You can track $NGVT on Quiver Quantitative's $NGVT stock dashboard.
$NGVT Stock Hedge Fund Activity
We have seen 114 institutional investors add shares of $NGVT Stock stock to their portfolio, and 161 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 1,021,004 shares (-86.5%) from their portfolio in Q4 2025, for an estimated $60,423,016
- PRINCIPAL FINANCIAL GROUP INC added 475,907 shares (+269.9%) to their portfolio in Q4 2025, for an estimated $28,164,176
- BOSTON PARTNERS added 363,584 shares (+141.6%) to their portfolio in Q4 2025, for an estimated $21,516,901
- MILLENNIUM MANAGEMENT LLC removed 266,447 shares (-22.4%) from their portfolio in Q4 2025, for an estimated $15,768,333
- GOLDMAN SACHS GROUP INC added 245,620 shares (+137.7%) to their portfolio in Q4 2025, for an estimated $14,535,791
- SOUTHERNSUN ASSET MANAGEMENT, LLC removed 160,701 shares (-37.1%) from their portfolio in Q4 2025, for an estimated $9,510,285
- MARSHALL WACE, LLP removed 157,078 shares (-68.8%) from their portfolio in Q4 2025, for an estimated $9,295,876
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$NGVT Stock Price Targets
Multiple analysts have issued price targets for $NGVT recently. We have seen 2 analysts offer price targets for $NGVT in the last 6 months, with a median target of $72.5.
Here are some recent targets:
- Michael Sison from Wells Fargo set a target price of $75.0 on 02/27/2026
- John McNulty from BMO Capital set a target price of $70.0 on 12/10/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
